Special Drug Use-results Survey for Long-term Use（Avacopan）
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorKissei Pharmaceutical Co., Ltd.
About this trial
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Disqualifiers
None
Trial population
Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Avacopan
Drugoral administration
Treatment groups
250 Participants
are divided into 1 treatment groupGroup A: Avacopan treatmented1 intervention
Trial outcomes
Primary outcomes
1
Adverse events
Time frame
2 yearsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Research siteRecruiting Multiple Locations
Japan
JapanSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov